SCP & CO has leveraged its expertise in healthcare and technology to take advantage of near-term market dynamics and favorable long-term secular trends in digital health by forming SCP & CO Healthcare Acquisition Company. Please visit our digital health SPAC for complete details. Below is an overview of the audiences who can best take advantage of a SPAC business combination, plus the differentiation points of SCP & CO Healthcare Acquisition Company.
Special purpose acquisition companies (SPAC’s) are rapidly becoming the IPO vehicle of choice in the public markets. Most SPAC’s are seeking high-growth, middle market businesses with Enterprise Values ranging from approximately $250 million to $5 billion. For founders and shareholders of companies that fit this profile, SPAC’s have become a desirable alternative to the traditional IPO process. There are two primary audiences who should educate themselves about SPAC’s, the founders and the funding sources:
There are numerous advantages to high-growth, middle market businesses using a SPAC as its vehicle to access the public markets. While in the past, these special purpose acquisition companies were a seldom-used, rarely mentioned financial instrument, they have achieved broad market acceptance and are now a commonplace, if not preferred method of IPO. With a broad range of digital health expertise and connectivity, SCP & CO is the right partner for your healthcare technology company. Our track record of growth and commitment in the healthcare space is well documented. We have captured the investor demand and liquidity that can ensure a successful transition to the public markets for your business.
An exit to the public markets is well-suited for high growth, middle-market companies that have received multiple rounds of venture capital funding. Additionally, there have been several successful spinoffs to SPAC’s of operating businesses within existing publicly-traded companies.
Since its inception in 2002, SCP& CO has completed eighty transactions totaling $1.8+ billion of aggregate transaction volume. Over half of the firm’s transactions have been platform acquisitions, financings, or add-on’s for SCP& CO’s Principals’ buyout control investment vehicles.